Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Charles Schwab Investment Management Inc.

Key Points

• Charles Schwab Investment Management Inc. increased its holdings in Intuitive Surgical, Inc. by 2.9% in the first quarter, owning approximately 0.67% of the company, valued at over $1.18 billion.
• Several hedge funds significantly modified their positions in Intuitive Surgical, with Chilton Capital Management raising its stake by 614.3%.
• Intuitive Surgical reported a 21.4% increase in quarterly revenue year-over-year, achieving an EPS of $2.19, surpassing analyst expectations.

Charles Schwab Investment Management Inc. raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,385,472 shares of the medical equipment provider's stock after buying an additional 67,803 shares during the period. Charles Schwab Investment Management Inc. owned about 0.67% of Intuitive Surgical worth $1,181,453,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. GAMMA Investing LLC lifted its holdings in shares of Intuitive Surgical by 54,010.7% in the first quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after purchasing an additional 3,022,979 shares in the last quarter. Capital Research Global Investors lifted its stake in Intuitive Surgical by 25.5% during the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock valued at $1,764,904,000 after acquiring an additional 687,906 shares in the last quarter. Goldman Sachs Group Inc. boosted its holdings in Intuitive Surgical by 26.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider's stock worth $1,396,496,000 after acquiring an additional 584,375 shares during the last quarter. Northern Trust Corp grew its stake in shares of Intuitive Surgical by 15.8% in the 4th quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock worth $1,889,126,000 after acquiring an additional 494,496 shares in the last quarter. Finally, Vanguard Group Inc. grew its stake in shares of Intuitive Surgical by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider's stock worth $16,178,258,000 after acquiring an additional 453,335 shares in the last quarter. Institutional investors own 83.64% of the company's stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of research analyst reports. Royal Bank Of Canada boosted their target price on Intuitive Surgical from $605.00 to $615.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 23rd. Wells Fargo & Company increased their price target on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a research report on Wednesday, July 23rd. Citigroup reaffirmed a "buy" rating and set a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Erste Group Bank reaffirmed a "hold" rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Finally, BTIG Research increased their price target on Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research report on Wednesday, July 23rd. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $595.95.

Intuitive Surgical Trading Up 0.1%

Shares of ISRG traded up $0.27 during trading hours on Friday, hitting $470.08. The company had a trading volume of 1,445,546 shares, compared to its average volume of 2,319,941. The company has a market capitalization of $168.51 billion, a PE ratio of 65.56, a price-to-earnings-growth ratio of 4.93 and a beta of 1.59. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The company's fifty day moving average price is $516.52 and its two-hundred day moving average price is $528.79.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The firm had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same quarter in the prior year, the business posted $1.78 EPS. The business's revenue for the quarter was up 21.4% compared to the same quarter last year. Analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the transaction, the senior vice president directly owned 907 shares of the company's stock, valued at $510,740.77. This trade represents a 19.23% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. The trade was a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,903 shares of company stock worth $7,932,778 in the last 90 days. Insiders own 0.70% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.